![]() |
brentuximab vedotin |
---|---|
Trade Name | Adcetris |
Orphan Indication | Enteropathy-associated T-cell lymphoma |
USA Market Approval | USA |
USA Designation Date | 2016-07-07 00:00:00 |
Sponsor | Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 |